Advertisement

Ads Placeholder
Analyst Ratings

RBC Maintains Outperform for Calian Group Ltd. (CLNFF) Feb 13, 2026

February 14, 2026
4 min read
Share with:

On Feb 13, 2026, RBC Capital maintained Outperform on Calian Group Ltd. (CLNFF). RBC also raised its price target to C$78 from C$66. The CLNFF analyst rating update signals RBC’s firmer outlook after recent company commentary. The market saw a small intraday move of 0.23% or $0.12. Market capitalization stands at $594,559,186. We use Meyka AI’s real-time coverage to track these changes and put the call in the context of Calian’s Q1 2026 results.

CLNFF analyst rating: RBC’s Feb 13, 2026 note

RBC Capital on Feb 13, 2026 kept Calian at Outperform and lifted the target to C$78 from C$66. The change was reported by The Fly and is recorded as a maintained Outperform action. Read the note on TheFly.

Advertisement

CLNFF price target change and specifics

RBC raised the price objective by C$12 to C$78. The firm preserved its Outperform stance while increasing implied valuation. TheFly reports the update and shows a modest intraday price move of 0.23% or $0.12 on the announcement.

Calian Group Ltd. analyst rating context and recent company news

Calian’s Q1 2026 earnings call highlighted ventures and co-development initiatives. That operating context likely informed RBC’s reassessment. See the Q1 call transcript for detail on strategy and pipeline at Seeking Alpha.

What the maintained Outperform means for investors

A maintained Outperform is effectively a bullish hold with expectations of above-market returns. Investors should compare RBC’s C$78 target to their entry price and risk tolerance. Without a public price at the note’s timestamp, the target defines expected upside, not a guaranteed outcome.

Historical analyst coverage and how this fits

Recent coverage of CLNFF is limited but includes notable shops like RBC Capital. This single Feb 13, 2026 action raised the target while keeping the Outperform rating, showing continuity in bullish sentiment from that analyst. Investors should watch for further coverage to build a broader consensus.

Meyka grade and modelling note

Meyka AI rates CLNFF with a grade of B+. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are not guaranteed and we are not financial advisors. Use them as one input alongside analyst notes and company results.

Final Thoughts

RBC’s Feb 13, 2026 maintenance of Outperform for Calian Group Ltd. and the lift of the price target to C$78 is a clear vote of confidence from a major bank. The CLNFF analyst rating and higher target reflect RBC’s positive view on Calian’s growth trajectory after the Q1 2026 call. For investors, the change is actionable only when compared against your purchase price and risk profile. The raise to C$78 increases implied upside for holders and prospective buyers, but it does not guarantee results. Market reaction was muted, with a 0.23% intraday move of $0.12, indicating the update was already partly priced in or seen as incremental. Given the company’s market cap of $594,559,186 and the single noted analyst action, we recommend monitoring further coverage and upcoming operational updates. Meyka AI’s real-time tools can track follow-up analyst notes and price moves to help assess whether the CLNFF analyst rating trend strengthens or reverses over time.

Advertisement

FAQs

What did RBC do for Calian on Feb 13, 2026?

RBC Capital maintained an Outperform rating and raised its price target to C$78 from C$66 on Feb 13, 2026. The update was reported by The Fly and listed as a maintained Outperform action with a small intraday price move of 0.23%.

How should investors interpret the CLNFF analyst rating?

The CLNFF analyst rating of Outperform signals RBC expects above-market returns versus peers. Investors should compare the C$78 target to current market price, weigh company fundamentals, and treat the rating as one input in portfolio decisions.

Does the price target raise mean buy now?

A higher price target by RBC raises implied upside but does not mandate buying. Evaluate Calian’s Q1 2026 outlook, market cap of $594,559,186, personal risk tolerance, and other analyst views before acting.

Where can I read the sources behind this update?

RBC’s update was reported on The Fly and you can review Calian’s Q1 2026 call transcript on Seeking Alpha. See the announcement at TheFly and the transcript at [Seeking Alpha](<

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Analyst ratings are opinions and not guarantees of future performance. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.

Advertisement

Ads Placeholder
Meyka Newsletter
Get analyst ratings, AI forecasts, and market updates in your inbox every morning.
~15% average open rate and growing
Trusted by 10,000+ active investors
Free forever. No spam. Unsubscribe anytime.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask our AI about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)